Zobrazeno 1 - 10 of 24 pro vyhledávání: '"Rowczenio, DM"'
2
Late-Onset Cryopyrin-Associated Periodic Syndromes Caused by Somatic NLRP3 Mosaicism—UK Single Center Experience
Autor: Rowczenio, DM, Melo Gomes, S, Aróstegui, JI, Mensa-Vilaro, A, Omoyinmi, E, Trojer, H, Baginska, A, Baroja-Mazo, A, Pelegrin, P, Savic, S, Lane, T, Williams, R, Brogan, P, Lachmann, HJ, Hawkins, PN
Publikováno v: Frontiers in Immunology, Vol 8 (2017)
Frontiers in Immunology
Cryopyrin-associated periodic syndrome (CAPS) is caused by gain-of-function NLRP3 mutations. Recently, somatic NLRP3 mosaicism has been reported in some CAPS patients who were previously classified as “mutation-negative.” We describe here the cli
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::dd0701531b4d51c1778f0a28d557f23f
http://journal.frontiersin.org/article/10.3389/fimmu.2017.01410/full
Zobrazit plný text záznamu
3
Akademický článek
AA amyloidosis complicating hyperimmunoglobulinemia D with periodic fever syndrome: a report of two cases.
Autor: Lachmann HJ, Goodman HJB, Andrews PA, Gallagher H, Marsh J, Breuer S, Rowczenio DM, Bybee A, Hawkins PN
Publikováno v: Arthritis & Rheumatism; 2006 Jun, Vol. 54 Issue 6, p2010-2014, 5p
Zobrazit plný text záznamu
4
Akademický článek
British kindred with dominant FMF associated with high incidence of AA amyloidosis caused by novel MEFV variant, and a review of the literature.
Autor: Rowczenio DM; National Amyloidosis Centre, University College London, UK., Youngstein T; National Amyloidosis Centre, University College London, UK., Trojer H; National Amyloidosis Centre, University College London, UK., Omoyinmi E; University College London Great Ormond Street Institute of Child Health (ICH), London, UK., Baginska A; National Amyloidosis Centre, University College London, UK., Brogan P; University College London Great Ormond Street Institute of Child Health (ICH), London, UK., Papadopoulou C; National Amyloidosis Centre, University College London, UK., Rezk T; National Amyloidosis Centre, University College London, UK., Hawkins PN; National Amyloidosis Centre, University College London, UK., Lachmann HJ; National Amyloidosis Centre, University College London, UK.
Publikováno v: Rheumatology (Oxford, England) [Rheumatology (Oxford)] 2020 Mar 01; Vol. 59 (3), pp. 554-558.
Zobrazit plný text záznamu
5
Akademický článek
Exploratory Study of MYD88 L265P, Rare NLRP3 Variants, and Clonal Hematopoiesis Prevalence in Patients With Schnitzler Syndrome.
Autor: Pathak S; NIHR, Leeds, UK., Rowczenio DM; University College London, London, UK., Owen RG; St. James's University Hospital, Leeds, UK., Doody GM; University of Leeds, UK., Newton DJ; University of Leeds, UK., Taylor C; University of Leeds, UK., Taylor J; St. James's University Hospital, Leeds, UK., Cargo C; St. James's University Hospital, Leeds, UK., Hawkins PN; University College London, London, UK., Krause K; Charité Universitätsmedizin Berlin, Berlin, Germany., Lachmann HJ; University College London, London, UK., Savic S; NIHR, Leeds, UK.
Publikováno v: Arthritis & rheumatology (Hoboken, N.J.) [Arthritis Rheumatol] 2019 Dec; Vol. 71 (12), pp. 2121-2125. Date of Electronic Publication: 2019 Oct 14.
Zobrazit plný text záznamu
6
Akademický článek
Natural History, Quality of Life, and Outcome in Cardiac Transthyretin Amyloidosis.
Autor: Lane T; National Amyloidosis Centre, Division of Medicine, University College London, United Kingdom (T.H., M.F., A.M.-N., C.C.Q., C.J.W., D.M.R., J.A.G., D.F.H., T.R., S.G.S., J.C.-G., R. Manwani, F.A.S., A.D.W., H.J.L., S.M., S.S., P.N.H., J.D.G.)., Fontana M; National Amyloidosis Centre, Division of Medicine, University College London, United Kingdom (T.H., M.F., A.M.-N., C.C.Q., C.J.W., D.M.R., J.A.G., D.F.H., T.R., S.G.S., J.C.-G., R. Manwani, F.A.S., A.D.W., H.J.L., S.M., S.S., P.N.H., J.D.G.)., Martinez-Naharro A; National Amyloidosis Centre, Division of Medicine, University College London, United Kingdom (T.H., M.F., A.M.-N., C.C.Q., C.J.W., D.M.R., J.A.G., D.F.H., T.R., S.G.S., J.C.-G., R. Manwani, F.A.S., A.D.W., H.J.L., S.M., S.S., P.N.H., J.D.G.)., Quarta CC; National Amyloidosis Centre, Division of Medicine, University College London, United Kingdom (T.H., M.F., A.M.-N., C.C.Q., C.J.W., D.M.R., J.A.G., D.F.H., T.R., S.G.S., J.C.-G., R. Manwani, F.A.S., A.D.W., H.J.L., S.M., S.S., P.N.H., J.D.G.)., Whelan CJ; National Amyloidosis Centre, Division of Medicine, University College London, United Kingdom (T.H., M.F., A.M.-N., C.C.Q., C.J.W., D.M.R., J.A.G., D.F.H., T.R., S.G.S., J.C.-G., R. Manwani, F.A.S., A.D.W., H.J.L., S.M., S.S., P.N.H., J.D.G.)., Petrie A; National Amyloidosis Centre, Division of Medicine, University College London, United Kingdom (T.H., M.F., A.M.-N., C.C.Q., C.J.W., D.M.R., J.A.G., D.F.H., T.R., S.G.S., J.C.-G., R. Manwani, F.A.S., A.D.W., H.J.L., S.M., S.S., P.N.H., J.D.G.)., Rowczenio DM; National Amyloidosis Centre, Division of Medicine, University College London, United Kingdom (T.H., M.F., A.M.-N., C.C.Q., C.J.W., D.M.R., J.A.G., D.F.H., T.R., S.G.S., J.C.-G., R. Manwani, F.A.S., A.D.W., H.J.L., S.M., S.S., P.N.H., J.D.G.)., Gilbertson JA; National Amyloidosis Centre, Division of Medicine, University College London, United Kingdom (T.H., M.F., A.M.-N., C.C.Q., C.J.W., D.M.R., J.A.G., D.F.H., T.R., S.G.S., J.C.-G., R. Manwani, F.A.S., A.D.W., H.J.L., S.M., S.S., P.N.H., J.D.G.)., Hutt DF; National Amyloidosis Centre, Division of Medicine, University College London, United Kingdom (T.H., M.F., A.M.-N., C.C.Q., C.J.W., D.M.R., J.A.G., D.F.H., T.R., S.G.S., J.C.-G., R. Manwani, F.A.S., A.D.W., H.J.L., S.M., S.S., P.N.H., J.D.G.)., Rezk T; National Amyloidosis Centre, Division of Medicine, University College London, United Kingdom (T.H., M.F., A.M.-N., C.C.Q., C.J.W., D.M.R., J.A.G., D.F.H., T.R., S.G.S., J.C.-G., R. Manwani, F.A.S., A.D.W., H.J.L., S.M., S.S., P.N.H., J.D.G.)., Strehina SG; National Amyloidosis Centre, Division of Medicine, University College London, United Kingdom (T.H., M.F., A.M.-N., C.C.Q., C.J.W., D.M.R., J.A.G., D.F.H., T.R., S.G.S., J.C.-G., R. Manwani, F.A.S., A.D.W., H.J.L., S.M., S.S., P.N.H., J.D.G.)., Caringal-Galima J; National Amyloidosis Centre, Division of Medicine, University College London, United Kingdom (T.H., M.F., A.M.-N., C.C.Q., C.J.W., D.M.R., J.A.G., D.F.H., T.R., S.G.S., J.C.-G., R. Manwani, F.A.S., A.D.W., H.J.L., S.M., S.S., P.N.H., J.D.G.)., Manwani R; National Amyloidosis Centre, Division of Medicine, University College London, United Kingdom (T.H., M.F., A.M.-N., C.C.Q., C.J.W., D.M.R., J.A.G., D.F.H., T.R., S.G.S., J.C.-G., R. Manwani, F.A.S., A.D.W., H.J.L., S.M., S.S., P.N.H., J.D.G.)., Sharpley FA; National Amyloidosis Centre, Division of Medicine, University College London, United Kingdom (T.H., M.F., A.M.-N., C.C.Q., C.J.W., D.M.R., J.A.G., D.F.H., T.R., S.G.S., J.C.-G., R. Manwani, F.A.S., A.D.W., H.J.L., S.M., S.S., P.N.H., J.D.G.)., Wechalekar AD; National Amyloidosis Centre, Division of Medicine, University College London, United Kingdom (T.H., M.F., A.M.-N., C.C.Q., C.J.W., D.M.R., J.A.G., D.F.H., T.R., S.G.S., J.C.-G., R. Manwani, F.A.S., A.D.W., H.J.L., S.M., S.S., P.N.H., J.D.G.)., Lachmann HJ; National Amyloidosis Centre, Division of Medicine, University College London, United Kingdom (T.H., M.F., A.M.-N., C.C.Q., C.J.W., D.M.R., J.A.G., D.F.H., T.R., S.G.S., J.C.-G., R. Manwani, F.A.S., A.D.W., H.J.L., S.M., S.S., P.N.H., J.D.G.)., Mahmood S; National Amyloidosis Centre, Division of Medicine, University College London, United Kingdom (T.H., M.F., A.M.-N., C.C.Q., C.J.W., D.M.R., J.A.G., D.F.H., T.R., S.G.S., J.C.-G., R. Manwani, F.A.S., A.D.W., H.J.L., S.M., S.S., P.N.H., J.D.G.)., Sachchithanantham S; National Amyloidosis Centre, Division of Medicine, University College London, United Kingdom (T.H., M.F., A.M.-N., C.C.Q., C.J.W., D.M.R., J.A.G., D.F.H., T.R., S.G.S., J.C.-G., R. Manwani, F.A.S., A.D.W., H.J.L., S.M., S.S., P.N.H., J.D.G.)., Drage EPS; Eastman Dental Institute, University College London, United Kingdom (A.P.). IQVIA, London, United Kingdom (E.P.S.D., H.D.J., R. McDonald, O.B., A.C.)., Jenner HD; Eastman Dental Institute, University College London, United Kingdom (A.P.). IQVIA, London, United Kingdom (E.P.S.D., H.D.J., R. McDonald, O.B., A.C.)., McDonald R; Eastman Dental Institute, University College London, United Kingdom (A.P.). IQVIA, London, United Kingdom (E.P.S.D., H.D.J., R. McDonald, O.B., A.C.)., Bertolli O; Eastman Dental Institute, University College London, United Kingdom (A.P.). IQVIA, London, United Kingdom (E.P.S.D., H.D.J., R. McDonald, O.B., A.C.)., Calleja A; Eastman Dental Institute, University College London, United Kingdom (A.P.). IQVIA, London, United Kingdom (E.P.S.D., H.D.J., R. McDonald, O.B., A.C.)., Hawkins PN; National Amyloidosis Centre, Division of Medicine, University College London, United Kingdom (T.H., M.F., A.M.-N., C.C.Q., C.J.W., D.M.R., J.A.G., D.F.H., T.R., S.G.S., J.C.-G., R. Manwani, F.A.S., A.D.W., H.J.L., S.M., S.S., P.N.H., J.D.G.)., Gillmore JD; National Amyloidosis Centre, Division of Medicine, University College London, United Kingdom (T.H., M.F., A.M.-N., C.C.Q., C.J.W., D.M.R., J.A.G., D.F.H., T.R., S.G.S., J.C.-G., R. Manwani, F.A.S., A.D.W., H.J.L., S.M., S.S., P.N.H., J.D.G.).
Publikováno v: Circulation [Circulation] 2019 Jul 02; Vol. 140 (1), pp. 16-26. Date of Electronic Publication: 2019 May 21.
Zobrazit plný text záznamu
7
Akademický článek
How to prescribe a genetic test for the diagnosis of autoinflammatory diseases?
Autor: Rowczenio DM; University College London, National Amyloidosis Centre, Rowland Hill Street, London NW3 2PF, United Kingdom. Electronic address: d.rowczenio@ucl.ac.uk., Lachmann HJ; University College London, National Amyloidosis Centre, Rowland Hill Street, London NW3 2PF, United Kingdom.
Publikováno v: Presse medicale (Paris, France : 1983) [Presse Med] 2019 Feb; Vol. 48 (1 Pt 2), pp. e49-e59. Date of Electronic Publication: 2019 Jan 18.
Zobrazit plný text záznamu
8
Akademický článek
Molecular genetic investigation, clinical features, and response to treatment in 21 patients with Schnitzler syndrome.
Autor: Rowczenio DM; National Amyloidosis Centre, University College London (UCL), London, United Kingdom., Pathak S; Leeds Musculoskeletal Biomedical Research Centre, National Institute for Health Research, Leeds, United Kingdom.; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, United Kingdom., Arostegui JI; Department of Immunology, Hospital Clinic, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain., Mensa-Vilaro A; Department of Immunology, Hospital Clinic, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain., Omoyinmi E; Great Ormond Street Institute of Child Health (ICH), UCL, London, United Kingdom., Brogan P; Great Ormond Street Institute of Child Health (ICH), UCL, London, United Kingdom., Lipsker D; Faculty of Medicine, University of Strasbourg, Strasbourg, France.; Dermatological Clinic, The University Hospitals of Strasbourg, Strasbourg, France; and., Scambler T; Leeds Musculoskeletal Biomedical Research Centre, National Institute for Health Research, Leeds, United Kingdom.; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, United Kingdom., Owen R; Department of Haematology, St. James's University Hospital, Leeds, United Kingdom., Trojer H; National Amyloidosis Centre, University College London (UCL), London, United Kingdom., Baginska A; National Amyloidosis Centre, University College London (UCL), London, United Kingdom., Gillmore JD; National Amyloidosis Centre, University College London (UCL), London, United Kingdom., Wechalekar AD; National Amyloidosis Centre, University College London (UCL), London, United Kingdom., Lane T; National Amyloidosis Centre, University College London (UCL), London, United Kingdom., Williams R; National Amyloidosis Centre, University College London (UCL), London, United Kingdom., Youngstein T; National Amyloidosis Centre, University College London (UCL), London, United Kingdom., Hawkins PN; National Amyloidosis Centre, University College London (UCL), London, United Kingdom., Savic S; Leeds Musculoskeletal Biomedical Research Centre, National Institute for Health Research, Leeds, United Kingdom.; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, United Kingdom., Lachmann HJ; National Amyloidosis Centre, University College London (UCL), London, United Kingdom.
Publikováno v: Blood [Blood] 2018 Mar 01; Vol. 131 (9), pp. 974-981. Date of Electronic Publication: 2017 Dec 28.
Zobrazit plný text záznamu
9
Akademický článek
International multi-centre study of pregnancy outcomes with interleukin-1 inhibitors.
Autor: Youngstein T; National Amyloidosis Centre, University College London Medical School, London, UK., Hoffmann P; National Human Genome Research Institute, National Institute of Health, Bethesda, MD, USA., Gül A; Division of Rheumatology, Istanbul Faculty of Medicine., Lane T; National Amyloidosis Centre, University College London Medical School, London, UK., Williams R; National Amyloidosis Centre, University College London Medical School, London, UK., Rowczenio DM; National Amyloidosis Centre, University College London Medical School, London, UK., Ozdogan H; Division of Rheumatology, Department of Internal Medicine, Cerrahpasa Medical School, Istanbul University, Istanbul, Turkey., Ugurlu S; Division of Rheumatology, Department of Internal Medicine, Cerrahpasa Medical School, Istanbul University, Istanbul, Turkey., Ryan J; Department of Rheumatology, Cork University Hospital, Cork, Ireland., Harty L; Department of Rheumatology, Cork University Hospital, Cork, Ireland., Riminton S; Department of Immunology, Concord Hospital, Sydney, Australia., Headley AP; Department of Immunology, Concord Hospital, Sydney, Australia., Roesler J; Department of Paediatric Immunology, University Hospital Carl Gustav Carus, Dresden., Blank N; Division of Rheumatology, University of Heidelberg, Heidelberg., Kuemmerle-Deschner JB; Division of Pediatric Rheumatology, Department of Pediatrics, University Hospital Tuebingen, Germany., Simon A; General Internal Medicine, Raboud University, Nijmegen, Netherlands., Woolf AS; Manchester Academic Health Sciences Centre, Royal Manchester Children's Hospital, Manchester, UK., Hawkins PN; National Amyloidosis Centre, University College London Medical School, London, UK., Lachmann HJ; National Amyloidosis Centre, University College London Medical School, London, UK.
Publikováno v: Rheumatology (Oxford, England) [Rheumatology (Oxford)] 2017 Dec 01; Vol. 56 (12), pp. 2102-2108.
Zobrazit plný text záznamu
10
Akademický článek
Changing epidemiology of AA amyloidosis: clinical observations over 25 years at a single national referral centre.
Autor: Lane T; a National Amyloidosis Centre, Division of Medicine, Centre for Amyloidosis and Acute Phase Proteins , University College London , London , UK., Pinney JH; a National Amyloidosis Centre, Division of Medicine, Centre for Amyloidosis and Acute Phase Proteins , University College London , London , UK., Gilbertson JA; a National Amyloidosis Centre, Division of Medicine, Centre for Amyloidosis and Acute Phase Proteins , University College London , London , UK., Hutt DF; a National Amyloidosis Centre, Division of Medicine, Centre for Amyloidosis and Acute Phase Proteins , University College London , London , UK., Rowczenio DM; a National Amyloidosis Centre, Division of Medicine, Centre for Amyloidosis and Acute Phase Proteins , University College London , London , UK., Mahmood S; a National Amyloidosis Centre, Division of Medicine, Centre for Amyloidosis and Acute Phase Proteins , University College London , London , UK., Sachchithanantham S; a National Amyloidosis Centre, Division of Medicine, Centre for Amyloidosis and Acute Phase Proteins , University College London , London , UK., Fontana M; a National Amyloidosis Centre, Division of Medicine, Centre for Amyloidosis and Acute Phase Proteins , University College London , London , UK., Youngstein T; a National Amyloidosis Centre, Division of Medicine, Centre for Amyloidosis and Acute Phase Proteins , University College London , London , UK., Quarta CC; a National Amyloidosis Centre, Division of Medicine, Centre for Amyloidosis and Acute Phase Proteins , University College London , London , UK., Wechalekar AD; a National Amyloidosis Centre, Division of Medicine, Centre for Amyloidosis and Acute Phase Proteins , University College London , London , UK., Gillmore JD; a National Amyloidosis Centre, Division of Medicine, Centre for Amyloidosis and Acute Phase Proteins , University College London , London , UK., Hawkins PN; a National Amyloidosis Centre, Division of Medicine, Centre for Amyloidosis and Acute Phase Proteins , University College London , London , UK., Lachmann HJ; a National Amyloidosis Centre, Division of Medicine, Centre for Amyloidosis and Acute Phase Proteins , University College London , London , UK.
Publikováno v: Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis [Amyloid] 2017 Sep; Vol. 24 (3), pp. 162-166. Date of Electronic Publication: 2017 Jul 07.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje